Figure 4.
Figure 4. Modulation of the Hh pathway modifies the level of differentiation of K562 cells. (A-D) Cells were treated for 72 hours with either medium (control, gray) or 5 μg/mL MVs generated from PHA/PMA/act D-treated CEM T cells in the absence (blue trace) or in the presence of either 30 μM cyclopamine (red trace, A-B), 1:150 anti-Smo (red trace, C-D), or 1:150 preimmune sera (green trace, C-D). (E, F) Cells were treated with medium (gray), 1 nM (blue trace), or 3 nM (red trace) SAG (agonist of Smo) for 72 hours. Detection of αIIbβ3 and CD42b expression was performed by flow cytometry after labeling by the corresponding antibody. Fluorescence (FL2, red fluorescence channel intensity) is expressed in arbitrary units (au). Data are representative of 8 experiments yielding similar results.

Modulation of the Hh pathway modifies the level of differentiation of K562 cells. (A-D) Cells were treated for 72 hours with either medium (control, gray) or 5 μg/mL MVs generated from PHA/PMA/act D-treated CEM T cells in the absence (blue trace) or in the presence of either 30 μM cyclopamine (red trace, A-B), 1:150 anti-Smo (red trace, C-D), or 1:150 preimmune sera (green trace, C-D). (E, F) Cells were treated with medium (gray), 1 nM (blue trace), or 3 nM (red trace) SAG (agonist of Smo) for 72 hours. Detection of αIIbβ3 and CD42b expression was performed by flow cytometry after labeling by the corresponding antibody. Fluorescence (FL2, red fluorescence channel intensity) is expressed in arbitrary units (au). Data are representative of 8 experiments yielding similar results.

Close Modal

or Create an Account

Close Modal
Close Modal